Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kyle

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|August 1, 1989
Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effectsV Kyle, B L Hazleman
Endocrine Research|January 1, 1992
ACTH immunoactivity in normal rat tissues: modulation by hypophysectomy and adrenalectomyC V Kyle, W D Odell
The Australian & New Zealand Journal of Obstetrics & Gynaecology|October 11, 2001
Screening for gestational diabetes mellitus: can we be more efficient?C V Kyle, T F Cundy
The American Journal of the Medical Sciences|January 1, 1992
Chronic fatigue syndrome: a conundrumD V Kyle, R D deShazo
Journal of Clinical Lipidology|May 16, 2017
A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicingAndrew D Laurie, Campbell V Kyle
The Journal of Rheumatology|September 1, 1992
Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenonM V Kyle, G Belcher, B L Hazleman
Clinical Rheumatology|September 1, 1991
Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritisV Kyle, E P Wraight, B L Hazleman
Annals of the Rheumatic Diseases|April 1, 1983
Yttrium-90 therapy and 99MTc pertechnetate knee uptake measurements in the management of rheumatoid arthritisV Kyle, B L Hazleman, E P Wraight
Annals of the Rheumatic Diseases|August 1, 1989
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow upV Kyle, T E Cawston, B L Hazleman
Postgraduate Medical Journal|January 5, 2000
OSCEs for house officersV Kyle, C Burns-Cox, L Box, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|August 1, 1989
Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effectsV Kyle, B L Hazleman
Endocrine Research|January 1, 1992
ACTH immunoactivity in normal rat tissues: modulation by hypophysectomy and adrenalectomyC V Kyle, W D Odell
The Australian & New Zealand Journal of Obstetrics & Gynaecology|October 11, 2001
Screening for gestational diabetes mellitus: can we be more efficient?C V Kyle, T F Cundy
The American Journal of the Medical Sciences|January 1, 1992
Chronic fatigue syndrome: a conundrumD V Kyle, R D deShazo
Journal of Clinical Lipidology|May 16, 2017
A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicingAndrew D Laurie, Campbell V Kyle
The Journal of Rheumatology|September 1, 1992
Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenonM V Kyle, G Belcher, B L Hazleman
Clinical Rheumatology|September 1, 1991
Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritisV Kyle, E P Wraight, B L Hazleman
Annals of the Rheumatic Diseases|April 1, 1983
Yttrium-90 therapy and 99MTc pertechnetate knee uptake measurements in the management of rheumatoid arthritisV Kyle, B L Hazleman, E P Wraight
Annals of the Rheumatic Diseases|August 1, 1989
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow upV Kyle, T E Cawston, B L Hazleman
Postgraduate Medical Journal|January 5, 2000
OSCEs for house officersV Kyle, C Burns-Cox, L Box, et al.
Pageof 5